| Drug Name |
Ciclesonide |
| Drug ID |
BADD_D00460 |
| Description |
Ciclesonide is a glucocorticoid used to treat obstructive airway diseases. It is marketed under the brand name Alvesco. |
| Indications and Usage |
For the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis in adults and adolescents 12 years of age and older. |
| Marketing Status |
approved; investigational |
| ATC Code |
R01AD13; R03BA08 |
| DrugBank ID |
DB01410
|
| KEGG ID |
D01703
|
| MeSH ID |
C120481
|
| PubChem ID |
6918155
|
| TTD Drug ID |
D0K7HU
|
| NDC Product Code |
70515-711; 53104-7633; 70515-712; 70515-701; 64918-1900; 24002-0016; 64918-1112; 70515-737 |
| UNII |
S59502J185
|
| Synonyms |
ciclesonide | (R)-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with cyclohexanecarboxaldehyde, 21-isobutyrate | Alvesco | Omnaris |
